Actively Recruiting

Phase Not Applicable
FEMALE
NCT07032545

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Led by University of Maryland, Baltimore · Updated on 2025-12-23

24

Participants Needed

1

Research Sites

160 weeks

Total Duration

On this page

Sponsors

U

University of Maryland, Baltimore

Lead Sponsor

U

University of Maryland, College Park

Collaborating Sponsor

AI-Summary

What this Trial Is About

Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer. Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals. This study will test whether BMG can be a useful addition to the diet of obese breast cancer (BC) survivors who have a higher risk of their cancer returning. 24 obese BC survivors will be invited to eat one serving (one cup, \~57 gram) of fresh BMG every day for two weeks. This will help understand if people can stick to this diet, how their bodies respond, and whether it affects metabolism and inflammation-two key factors linked to cancer risk. Biological markers such as body fat, glucose and lipids as well as gut bacterial changes will be analyzed to see how BMG affects individual health. This study may help create new diet strategies to improve health, reduce cancer risk, and support long-term recovery in cancer patients who are overweight or obese. In the future, this research could help doctors personalize nutrition plans to better support cancer survivors.

CONDITIONS

Official Title

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Who Can Participate

FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female
  • Diagnosed with breast cancer (Stage I-III)
  • 2 to 60 months post-curative treatment including surgery, chemotherapy, and/or radiation
  • Body mass index (BMI) greater than 30 kg/m² (obese classification)
  • Willing to avoid cruciferous vegetables during the study
  • Able to sign an IRB-approved consent form
Not Eligible

You will not qualify if you...

  • Contraindications to the nutrition intervention as identified by a medical provider or study team (e.g., gastrointestinal conditions, medication needs, pregnancy, breastfeeding, recent eating disorder)
  • Allergy or intolerance to cruciferous vegetables
  • Currently taking broccoli extract supplements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Baltimore, Maryland, United States, 21201

Actively Recruiting

Loading map...

Research Team

Y

Yuanyuan (Rose) Li, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here